Detailed information for compound 583303

Basic information

Technical information
  • TDR Targets ID: 583303
  • Name: 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophe nyl)methoxy]ethyl]imidazole; [2-[(6S,8S,10S,1 1S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-1 0,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17 -octahydro-6H-cyclopenta[a]phenanthren-17-yl] -2-oxo-ethyl] pentanoate; nitric acid
  • MW: 957.71 | Formula: C45H51Cl4F2N3O9
  • H donors: 2 H acceptors: 8 LogP: 9.8 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: Clc1ccc(c(c1)Cl)C(Cn1cncc1)OCc1c(Cl)cccc1Cl.[O-][N+](=O)O.CCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)C1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
  • InChi: 1S/C27H36F2O5.C18H14Cl4N2O.HNO3/c1-5-6-7-23(33)34-14-21(31)24-15(2)10-17-18-12-20(28)19-11-16(30)8-9-26(19,4)27(18,29)22(32)13-25(17,24)3;19-12-4-5-13(17(22)8-12)18(9-24-7-6-23-11-24)25-10-14-15(20)2-1-3-16(14)21;2-1(3)4/h8-9,11,15,17-18,20,22,24,32H,5-7,10,12-14H2,1-4H3;1-8,11,18H,9-10H2;(H,2,3,4)/t15-,17+,18+,20+,22+,24-,25+,26+,27?;;/m1../s1
  • InChiKey: UPINRYVXYNYCOF-UESYANRNSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole; nitric acid; pentanoic acid [2-[(6S,8S,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester
  • 1-[2-(2,6-dichlorobenzyl)oxy-2-(2,4-dichlorophenyl)ethyl]imidazole; nitric acid; valeric acid [2-[(6S,8S,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-3-keto-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-keto-ethyl] ester
  • 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole; [2-[(6S,8S,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] pentanoate; nitric acid
  • Travocort
  • 78940-01-9
  • Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16-methyl-21-((1-oxopentyl)oxy)-, (6alpha,11beta,16alpha)-, mixt. with 1-(2-(2,4-dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)-1H-imidazole mononitrate

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Trypanosoma cruzi hypothetical protein, conserved 0.0165 0.1395 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0086 0.0555 0.0393
Schistosoma mansoni alpha-glucosidase 0.0894 0.916 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0165 0.1395 0.3943
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Trichomonas vaginalis alpha-glucosidase, putative 0.0086 0.0555 0.0393
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.0165 0.1395 0.1098
Loa Loa (eye worm) hypothetical protein 0.0126 0.098 0.0669
Echinococcus multilocularis lysosomal alpha glucosidase 0.0973 1 1
Loa Loa (eye worm) O-glycosyl hydrolase family 30 protein 0.0299 0.2828 0.2581
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Trichomonas vaginalis alpha-glucosidase, putative 0.0086 0.0555 0.0393
Schistosoma mansoni bile acid beta-glucosidase-related 0.0241 0.221 0.2126
Brugia malayi Glycosyl hydrolases family 31 protein 0.0086 0.0555 0.0555
Echinococcus granulosus glycogen debranching enzyme 0.015 0.1241 0.0938
Echinococcus granulosus neutral alpha glucosidase AB 0.0165 0.1395 0.1098
Trichomonas vaginalis glycogen debranching enzyme, putative 0.015 0.1241 0.3291
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.0973 1 1
Leishmania major alpha glucosidase II subunit, putative 0.0165 0.1395 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0165 0.1395 0.3943
Echinococcus granulosus microtubule associated protein 2 0.0708 0.7184 0.7087
Echinococcus multilocularis lysosomal alpha glucosidase 0.0973 1 1
Echinococcus multilocularis bile acid beta glucosidase 0.0241 0.221 0.1941
Schistosoma mansoni ceramide glucosyltransferase 0.0553 0.5529 0.5886
Trypanosoma brucei glucosidase, putative 0.0165 0.1395 1
Schistosoma mansoni microtubule-associated protein tau 0.0708 0.7184 0.7761
Onchocerca volvulus Ceramide glucosyltransferase homolog 0.0553 0.5529 0.9073
Entamoeba histolytica glycosyl hydrolase, family 31 protein 0.0165 0.1395 1
Brugia malayi TAR-binding protein 0.0065 0.0333 0.0333
Brugia malayi O-Glycosyl hydrolase family 30 protein 0.0299 0.2828 0.2828
Echinococcus multilocularis microtubule associated protein 2 0.0708 0.7184 0.7087
Echinococcus multilocularis ceramide glucosyltransferase 0.0553 0.5529 0.5375
Toxoplasma gondii glycosyl hydrolase, family 31 protein 0.0165 0.1395 1
Schistosoma mansoni alpha glucosidase 0.0165 0.1395 0.1203
Trichomonas vaginalis glycogen debranching enzyme, putative 0.015 0.1241 0.3291
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0165 0.1395 0.3943
Trichomonas vaginalis glucosylceramidase, putative 0.0207 0.1845 0.5844
Trichomonas vaginalis maltase-glucoamylase, putative 0.0086 0.0555 0.0393
Echinococcus multilocularis neutral alpha glucosidase AB 0.0165 0.1395 0.1098
Loa Loa (eye worm) transcription factor SMAD2 0.0123 0.0946 0.0634
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Loa Loa (eye worm) hypothetical protein 0.0126 0.098 0.0669
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0086 0.0555 0.0393
Trichomonas vaginalis glucosylceramidase, putative 0.0299 0.2828 1
Loa Loa (eye worm) amylo-alpha-1,6-glucosidase 0.0073 0.042 0.0089
Brugia malayi MH2 domain containing protein 0.0123 0.0946 0.0946
Trichomonas vaginalis glucosylceramidase, putative 0.0299 0.2828 1
Onchocerca volvulus 0.0601 0.6037 1
Echinococcus granulosus non lysosomal glucosylceramidase 0.0241 0.221 0.1941
Trichomonas vaginalis alpha-glucosidase, putative 0.0165 0.1395 0.3943
Trichomonas vaginalis glucosylceramidase, putative 0.0299 0.2828 1
Brugia malayi Amylo-alpha-1,6-glucosidase family protein 0.015 0.1241 0.1241
Trichomonas vaginalis glucosylceramidase, putative 0.0299 0.2828 1
Echinococcus granulosus ceramide glucosyltransferase 0.0553 0.5529 0.5375
Trichomonas vaginalis maltase-glucoamylase, putative 0.0165 0.1395 0.3943
Loa Loa (eye worm) hypothetical protein 0.0163 0.1375 0.1078
Schistosoma mansoni bile acid beta-glucosidase-related 0.0241 0.221 0.2126
Loa Loa (eye worm) MH2 domain-containing protein 0.0123 0.0946 0.0634
Trichomonas vaginalis glucosylceramidase, putative 0.0299 0.2828 1
Trichomonas vaginalis glucosylceramidase, putative 0.0299 0.2828 1
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Onchocerca volvulus Glucosylceramidase homolog 0.0196 0.1732 0.2147
Entamoeba histolytica glycosyl hydrolase, family 31 protein 0.0165 0.1395 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0086 0.0555 0.0393
Loa Loa (eye worm) hypothetical protein 0.015 0.1241 0.0938
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Echinococcus granulosus lysosomal alpha glucosidase 0.0973 1 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0165 0.1395 0.3943
Schistosoma mansoni alpha-glucosidase 0.0894 0.916 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0086 0.0555 0.0393
Trichomonas vaginalis sucrase-isomaltase, putative 0.0165 0.1395 0.3943
Brugia malayi RNA recognition motif domain containing protein 0.0065 0.0333 0.0333
Trichomonas vaginalis glucosylceramidase, putative 0.0196 0.1732 0.5368
Trypanosoma cruzi hypothetical protein, conserved 0.0165 0.1395 1
Trichomonas vaginalis alpha-glucosidase, putative 0.0165 0.1395 0.3943
Echinococcus multilocularis glycogen debranching enzyme 0.015 0.1241 0.0938
Schistosoma mansoni ceramide glucosyltransferase 0.0553 0.5529 0.5886
Brugia malayi Ceramide glucosyltransferase 0.0553 0.5529 0.5529
Giardia lamblia Ceramide glucosyltransferase 0.0251 0.231 1
Onchocerca volvulus Huntingtin homolog 0.0126 0.098 0.0775
Echinococcus multilocularis non lysosomal glucosylceramidase 0.0241 0.221 0.1941
Entamoeba histolytica glycogen debranching enzyme, putative 0.015 0.1241 0.8162
Brugia malayi Glycosyl hydrolases family 31 protein 0.0165 0.1395 0.1395
Trichomonas vaginalis glucosylceramidase, putative 0.0207 0.1845 0.5844
Loa Loa (eye worm) hypothetical protein 0.0086 0.0555 0.0229
Loa Loa (eye worm) ceramide glucosyltransferase 0.0553 0.5529 0.5375
Brugia malayi RNA binding protein 0.0065 0.0333 0.0333
Schistosoma mansoni hypothetical protein 0.0109 0.0796 0.0525
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0086 0.0555 0.0393
Echinococcus granulosus bile acid beta glucosidase 0.0241 0.221 0.1941
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0165 0.1395 0.3943
Brugia malayi hypothetical protein 0.0126 0.098 0.098
Onchocerca volvulus Huntingtin homolog 0.0126 0.098 0.0775
Schistosoma mansoni hypothetical protein 0.0193 0.1697 0.1545

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.